Additionally, IHC testing of CRC samples from the index case of Family 1 revealed a lack of PMS2 immunoreactivity, suggesting that the identified PMS2 missense variant likely affects PMS2 protein expression. This evidence concerns the gene PMS2 and colorectal carcinoma.